|
Video: What is a Stock Split?
|
|
Revance Therapeutics is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. Co.'s segments are: Product, which refers to the business that includes the research, development and commercialization of its product candidates and the RHA® Collection of dermal fillers; and Service, which refers to the business that includes the development and commercialization of the OPUL Relational Commerce Platform and HintMD platform. According to our Revance Therapeutics stock split history records, Revance Therapeutics has had 0 splits. | |
|
Revance Therapeutics (RVNC) has 0 splits in our Revance Therapeutics stock split history database.
Looking at the Revance Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Revance Therapeutics shares, starting with a $10,000 purchase of RVNC, presented on a split-history-adjusted basis factoring in the complete Revance Therapeutics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$35.21 |
|
End price/share: |
$3.29 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-90.66% |
|
Average Annual Total Return: |
-21.11% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$934.33 |
|
Years: |
10.00 |
|
|
|
|
|